Conference
Bleeding risk of Glycoprotein (GP) IIb IIIa inhibitors or thienopyridines with fondaparinux vs. enoxaparin in Acute Coronary Syndromes: insights from the OASIS 5 trial
Authors
Jolly S; Mehta SR; Widimsky P; Afzal R; Steg PG; Valentin V; Budaj A; Fox KAA; Granger CB; Yusuf S
Volume
28
Pagination
pp. 516-516
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2007
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X